Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies

Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Brendan Gibbons as its new Chief Legal Officer and corporate secretary.

Brendan joins Allurion with nearly 20 years’ experience as a chief legal and compliance officer at three separate public companies. Most recently, Brendan served as Executive Vice President and Chief Legal Officer at Acushnet Company, the parent company of Titleist and other golf brands and a global leader in product innovation, precision manufacturing, and performance. Prior to Acushnet, Brendan held similar roles at Wolverine Worldwide and Carter’s, Inc. Before going in-house, Brendan worked at Ropes & Gray LLP as a corporate and securities lawyer. Brendan holds bachelor’s degrees from the University of Pennsylvania and a juris doctorate from Boston College Law School.

In this new role, Brendan will lead the company’s legal and compliance strategies, playing a pivotal part in guiding the company's global expansion and upholding its commitment to delivering safe and effective weight loss solutions. Brendan will report directly to Dr. Shantanu Gaur, Allurion’s Founder and CEO, and will serve as key advisor to Dr. Gaur, Allurion’s senior management team, and its Board of Directors.

"We are thrilled to welcome Brendan to Allurion as our Chief Legal Officer," said Dr. Gaur. "His extensive legal experience and proven leadership skills will be instrumental as we continue to innovate and expand our global reach, while ensuring we uphold the highest legal and ethical standards as a publicly traded company.”

“I am incredibly excited to join Allurion at this exciting stage of its life cycle and be part of such an innovative company dedicated to transforming the lives of individuals through cutting-edge weight loss solutions,” said Mr. Gibbons. “I look forward to contributing to Allurion's mission."

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan, whether it is gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.